0 results for 'Fresenius'
Gibbons on the Case: New Jersey Firm Launches 15 Suits for Drug Company
The suits stem from defendants' submission to the U.S. Food and Drug Administration of Abbreviated New Drug Applications [ANDA] seeking permission to manufacture generic versions of American Regent's selenious acid products before their patents expire.Lawsuits Are Flying Over Generic-Drug Disputes: Surge in Patent Litigation
Five of the suits were filed by Esperion Therapeutics, which seeks to stop competitors from selling generic versions of the company's cholesterol drug Nexletol.'No Better Than a Racket'—Seventh Circuit Critical of Mootness Fees for Merger Disclosures
Judge Frank Easterbrook, disenchanted with the current "federal practice" of plaintiffs attorneys extorting fees in disclosure cases without conferring a meaningful benefit on stockholders, penned the opinion for a two-judge panel rejecting such fee agreements and empowering shareholders and federal courts alike to scrutinize these fees going forward.Record $41M Jury Verdict Awarded to Lawyer for Medical Malpractice Claims
"The jury's verdict is bittersweet for this wonderful family, which has been devastated by Craig Pierce's injury and the loss of his ability to function independently and practice law," Christopher Hurley, a founding partner at Hurley McKenna & Mertz, said in a statement.Big Law Squares Off in Battle Over Prescription Drug Prices
Courts have consistently rejected challenges under the Takings Clause to federal health care programs that seek to limit costs, according to an amicus curiae brief by a panel of nine nationally recognized experts in Medicare and medical finance.View more book results for the query "Fresenius"
Blue Chips Front Money for Buyers of Their Unwanted Assets
Dealmakers are dusting off their playbooks from the global financial crisis, devising creative ways to get transactions completed as traditional financing sources dry up.The Three Big Words at the Center of the Twitter Saga
Instances of a Delaware Court finding that a "material adverse effect" has occurred are few and far between, so a ruling that one has occurred in this case would have been atypical.Patents: Discretionary Denials and the Consequences of Gameplaying
This article is directed to such discretionary denials, and the difficulties arising from the lack of denial standards and from the gamesmanship of counsel, and the pending movement toward rulemaking to alleviate these concerns.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
2024 Trends Report Mid-Year Special Edition: Update on Outside Counsel Billing Rates
Brought to you by LexisNexis® CounselLink®
Download Now
AI in Private Equity: A Guide for Gaining an Early Advantage
Brought to you by Ontra
Download Now
Why Are So Many Law Firms Suddenly Embracing Digital Transformation?
Brought to you by AllRize
Download Now
2025 State Legislative Sessions
Brought to you by LexisNexis®
Download Now